Home › Scleroderma › New York › New York City
Studi clinici su Scleroderma a New York City, NY
11 studi su Scleroderma cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
In reclutamentoFase 3
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
In reclutamentoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
In reclutamentoFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
In reclutamentoFase 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
In reclutamentoFase 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
In reclutamentoFase 2/3
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
In reclutamentoFase 1/2
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
In reclutamentoFase 1
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
In reclutamentoFase 1
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
In reclutamentoFase 2
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
In reclutamentoFase 2
- aTyr Investigative Site, New York
Studi su Scleroderma in altre città
- Ann Arbor, MI10 studi
- Chicago, IL10 studi
- Houston, TX9 studi
- Boston, MA7 studi
- Durham, NC7 studi
- Los Angeles, CA7 studi
- New Orleans, LA6 studi
- Philadelphia, PA6 studi
- Baltimore, MD6 studi
- Dallas, TX5 studi
- Pittsburgh, PA5 studi
- Plantation, FL4 studi
Altri studi a New York City
- Cancro al seno134 studi
- Cancro del polmone non a piccole cellule120 studi
- Cancro (tutti i tipi)110 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale77 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Cancro pancreatico60 studi
- Mieloma multiplo60 studi
- Cancro dell'endometrio52 studi
- Insufficienza cardiaca51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.